Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-08-09
2011-08-09
Szperka, Michael (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S145100, C424S146100, C514S013500, C514S014300, C514S014500, C435S337000
Reexamination Certificate
active
07993644
ABSTRACT:
The present invention provides antibodies capable of binding to human tissue factor, which do not inhibit tissue factor mediated blood coagulation compared to a normal plasma control. Further described are methods of making and methods of using the antibodies of the invention.
REFERENCES:
patent: 5110730 (1992-05-01), Edgington et al.
patent: 5223427 (1993-06-01), Edgington et al.
patent: 5437864 (1995-08-01), Edgington et al.
patent: 5506134 (1996-04-01), Soule et al.
patent: 5534254 (1996-07-01), Huston et al.
patent: 5622931 (1997-04-01), Edgington et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5877289 (1999-03-01), Thorpe et al.
patent: 5932449 (1999-08-01), Emanuel et al.
patent: 5986065 (1999-11-01), Wong et al.
patent: 6001978 (1999-12-01), Edgington et al.
patent: 6004555 (1999-12-01), Thorpe et al.
patent: 6036955 (2000-03-01), Thorpe et al.
patent: 6093399 (2000-07-01), Thorpe et al.
patent: 6217866 (2001-04-01), Schlessinger et al.
patent: 6262238 (2001-07-01), Steipe et al.
patent: 6555319 (2003-04-01), Wong et al.
patent: 6677436 (2004-01-01), Sato et al.
patent: 7425328 (2008-09-01), Wang
patent: 2003/0082636 (2003-05-01), Wong et al.
patent: 2003/0109680 (2003-06-01), Wong et al.
patent: 2003/0119075 (2003-06-01), Kirchhofer et al.
patent: 2003/0124117 (2003-07-01), Refino et al.
patent: 2003/0176664 (2003-09-01), Jiao et al.
patent: 2004/0044187 (2004-03-01), Sato et al.
patent: 05-244988 (1993-09-01), None
patent: 2001-213804 (2001-08-01), None
patent: WO 94/05328 (1994-03-01), None
patent: WO 96/01653 (1996-01-01), None
patent: WO 97/09063 (1997-03-01), None
patent: WO 98/40408 (1998-09-01), None
patent: WO 01/02439 (2001-01-01), None
patent: WO 01/27079 (2001-04-01), None
patent: WO 01/70984 (2001-09-01), None
patent: WO 02/072600 (2002-09-01), None
patent: WO 03/020111 (2003-03-01), None
patent: WO 03/037911 (2003-05-01), None
patent: WO 03/093422 (2003-11-01), None
patent: WO 03/103711 (2003-12-01), None
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Rudikoff et al., Proc Natl Acad Sci U S A. Mar. 1982;79(6):1979-83.
William E. Paul, M.D., editor, Fundamental Immunology, 3d ed. Raven Press, 1993, p. 242.
Bromberg, M.E., et al., “Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation,”Proc. Natl. Acad. Sci. USA 92:8205-8209, National Academy of Sciences (1995).
Callander, N.S., et al., “Immunohistochemical Identification of Tissue Factor in Solid Tumors,”Cancer 70:1194-1201, J.B. Lippincott Company (1992).
Carson, S.D., et al., “An Inhibitory Monoclonal Antibody Against Human Tissue Factor,”Blood 70:490-493, American Society of Hematology (1987).
Carson, S.D, et al., “Monoclonal Antibodies Against Bovine Tissue Factor, Which Block Interaction With Factor VIIa,”Blood 66:152-156, American Society of Hematology (1985).
Contrino, J., et al., “In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease,”Nat. Med. 2:209-215, Nature Publishing Company (1996).
Drake, T.A., et al., “Selective Cellular Expression of Tissue Factor in Human Tissues,”Am. J. Pathol. 134:1087-1097, American Association of Pathologists (1989).
Ewan, V., et al., “Production of a Monoclonal Antibody with Anticoagulant Activity for Human Tissue Factor,”Fed. Proc. 42:521, Federation of American Societies for Experimental Biology (1983).
Ewan, V.A., and Rickles, F.R., “Production of a Monoclonal Antibody with Anticoagulant Activity for Human Tissue Factor,”J. Thromb. Haemost. 50:406, Blackwell Pub (1983).
Fiore, M.M., et al., “An Unusual Antibody That Blocks Tissue Factor/Factor VIIa Function by Inhibiting Cleavage Only of Macromolecular Substrates,”Blood 80:3127-3134, American Society of Hematology (1992).
Hancock, W.W., et al., “Immunohistological Studies with a Monoclonal Antibody to Human Tissue Factor : Normal Distribution and Usefulness as a Marker for Activated Macrophages,”Pathology 16:479-480, Abstracts of Annual Meeting (1984).
Hu, T., et al., “Procoagulant Activity in Cancer Cells is Dependent on Tissue Factor Expression,”Oncol. Res. 6:321-327, Elsevier Science (1994).
Hu, Z., and Garen, A., “Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer,”Proc. Natl. Acad. Sci. USA 98:12180-12185, National Academy of Sciences (2001).
Hu, Z., et al., “Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model,”Proc. Natl. Acad. Sci. USA 96:8161-8166, National Academy of Sciences (1999).
Koomagi, R., and Volm, M., “Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis,”Int. J. Cancer 79:19-22, Wiley-Liss (1998).
Morrissey, J.H., et al., “EC11 CD142(tissue factor) Workshop Panel Report,”Leucocyte Typing 6:742-746, Garland Pub. (1998).
Morrissey, J.H., et al., “Monoclonal antibody analysis of purified and cell-associated tissue factor,”Thromb. Res. 52:247-261, Pergamon Press (1988).
Ngo, C., et al., “CNTO 89, a Humanized Anti-Tissue Factor Monoclonal Antibody, Inhibits Lung Metastasis and Tumor Growth in MDA-MB-231 Breast Cancer Xenograft Models,”Pathophysiol. Haemost. Thromb. 33, supplement 1: 71, Radnor (Sep. 2003).
Nishi, T., et al., “Tissue Factor Expressed in Pituitary Adenoma Cells Contributes to the Development of Vascular Events in Pituitary Adenomas,”Cancer 86:1354-1361, Wiley (1999).
Rao, L.V., “Characterization of Anti-Tissue Factor Antibody and Its Use in Immunoaffinity Purification of Human Tissue Factor,”Thromb. Res. 51:373-384, Pergamon Press (1988).
Sawada, M., et al., “Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis,”Br. J. Cancer 79:472-477, Harcourt Brace and Company Ltd (1999).
Seto, S., et al., “Tissue Factor Expression in Human Colorectal Carcinoma: Correlation with Hepatic Metastasis and Impact on Prognosis,”Cancer 88:295-301, Wiley (2000).
Shen, B., et al., “Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells,”J. Biol. Chem. 276:5281-5286, American Society for Biochemistry and Molecular Biology (2001).
Shigemori, C., et al., “Tissue Factor Expression and Metastatic Potential of Colorectal Cancer,”J. Thromb. Haemost. 80:894-898, Blackwell Pub. (1998).
Tanaka, H., et al., “Purification of Glycosylated Apoprotein of Tissue Factor from Human Brain and Inhibition of its Procoagulant Activity by a Specific Antibody,”Thromb. Res. 40:745-756, Pergamon Press (1985).
Zacharski, L.R., et al., “Coagulation-Cancer Interaction In Situ in Renal Cell Carcinoma,”Blood 68:394-399, American Society of Hematology (1986).
Zacharski, L.R., et al., “Occurrence of Fibrin and Tissue Factor Antigen in Human Small Cell Carcinoma of the Lung,”Cancer Res. 43:3963-3968, American Association for Cancer Research (1983).
Zeldis, S.M., et. al., “Tissue factor (Thromboplastin): Localization to Plasma Membranes by Peroxidase-Conjugated Antibodies,”Science 175:766-768, American Association for the Advancement of Science (1972).
Patent Abstracts of Japan, English Language Abstract of JP 05-244988 (Document AL1).
Patent Abstracts of Japan, English Language Abstract of JP 2001-213804 (Document AN2).
The Investigational Drugs database, Drug Report for hATR-5, available online at http://www.iddb3.com/iddb3/iddb3—2/reports.display?id=42643&template=Drugs&i—query—id=3285868, last updated on Mar. 24, 2004, accessed on May 4, 2004, 1 page, Derwent Information Ltd.
The Investigational Drugs database, Drug Report for hOAT, av
Purdue Pharma L.P.
Sterne Kessler Goldstein & Fox P.L.L.C.
Szperka Michael
LandOfFree
Tissue factor antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue factor antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue factor antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2753526